Items where Author is "Reeder, S"

RUTELLA, S., VADAKEKOLATHU, J., MAZZIOTTA, F., REEDER, S., YAU, T.-O., MUKHOPADHYAY, R., DICKINS, B., ALTMANN, H., KRAMER, M., KNAUS, H.A., BLAZAR, B.R., RADOJCIC, V., ZEIDNER, J.F., ARRUDA, A., WANG, B., ABBAS, H.A., MINDEN, M.D., TASIAN, S.K., BORNHÄUSER, M., GOJO, I. and LUZNIK, L., 2022. Signatures of immune dysfunction predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. Journal of Clinical Investigation. ISSN 0021-9738

LE VU, P., VADAKEKOLATHU, J., IDRI, S., NICHOLLS, H., CAVAIGNAC, M., REEDER, S., KHAN, M.A., CHRISTENSEN, D., POCKLEY, A.G. and MCARDLE, S.E., 2022. A mutated prostatic acid phosphatase (PAP) peptide-based vaccine induces PAP-specific CD8+ T cells with ex vivo cytotoxic capacities in HHDII/DR1 transgenic mice. Cancers, 14 (8): 1970. ISSN 2072-6694

COSMA, G., MCARDLE, S.E., FOULDS, G.A., HOOD, S.P., REEDER, S., JOHNSON, C., KHAN, M.A. and POCKLEY, A.G., 2021. Prostate cancer: early detection and assessing clinical risk using deep machine learning of high dimensional peripheral blood flow cytometric phenotyping data. Frontiers in Immunology, 12: 786828. ISSN 1664-3224

ALMSHAYAKHCHI, R., NAGARAJAN, D., VADAKEKOLATHU, J., GUINN, B.-A., REEDER, S., BRENTVILLE, V., METHERINGHAM, R., POCKLEY, A.G., DURRANT, L. and MCARDLE, S., 2021. A novel HAGE/WT1-ImmunoBody® vaccine combination enhances anti-tumour responses when compared to either vaccine alone. Frontiers in Oncology, 11: 636977.

VADAKEKOLATHU, J., LAI, C., REEDER, S., CHURCH, S.E., HOOD, T., LOURDUSAMY, A., RETTIG, M.P., ALDOSS, I., ADVANI, A.S., GODWIN, J., WIEDUWILT, M.J., ARELLANO, M., MUTH, J., YAU, T.O., RAVANDI, F., SWEET, K., ALTMANN, H., FOULDS, G.A., STÖLZEL, F., MIDDEKE, J.M., CICIARELLO, M., CURTI, A., VALK, P.J.M., LÖWENBERG, B., GOJO, I., BORNHÄUSER, M., DIPERSIO, J.F., DAVIDSON-MONCADA, J.K. and RUTELLA, S., 2020. TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood Advances, 4 (20), pp. 5011-5024. ISSN 2473-9529

HOOD, S.P., COSMA, G., FOULDS, G.A., JOHNSON, C., REEDER, S., MCARDLE, S.E., KHAN, M.A. and POCKLEY, A.G., 2020. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. eLife, 9: e50936.

VADAKEKOLATHU NARAYANAN, J., MINDEN, M.D., HOOD, T., CHURCH, S.E., REEDER, S., ALTMANN, H., SULLIVAN, A.H., VIBOCH, E.J., PATEL, T., IBRAHIMOVA, N., WARREN, S.E., ARRUDA, A., LIANG, Y., SMITH, T.H., FOULDS, G.A., BAILEY, M.D., GOWEN-MACDONALD, J., MUTH, J., SCHMITZ, M., POCKLEY, A.G., CESANO, A., VALK, P.J.M., LÖWENBERG, B., BORNHÄUSER, M., TASIAN, S.K., RETTIG, M.P., DAVIDSON-MONCADA, J., DIPERSIO, J.F. and RUTELLA, S., 2020. Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia. Science Translational Medicine, 12 (546): eaaz0463. ISSN 1946-6234

RUTELLA, S., CHURCH, S.E., VADAKEKOLATHU, J., REEDER, S., SULLIVAN, A.H., WARREN, S., BAUGHMAN, J., MUTH, J., PARK, H., URONIS, H., KANG, Y., NG, M.C.H., ENZINGER, P., LEE, K.W., HUBER, K., WYNTER-HORTON, A., LI, D., BANG, Y., DAVIDSON-MONCADA, J. and CATENACCI, D.V., 2019. Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA). Annals of Oncology, 30 (Supp5), v38-v39. ISSN 0923-7534

HOOD, S.P., FOULDS, G.A., IMRIE, H., REEDER, S., MCARDLE, S.E.B., KHAN, M. and POCKLEY, A.G., 2019. Phenotype and function of activated natural killer cells from patients with prostate cancer: patient-dependent responses to priming and IL-2 activation. Frontiers in Immunology, 9: 3169. ISSN 1664-3224

VADAKEKOLATHU NARAYANAN, J., REEDER, S., COVENEY, C. and RUTELLA, S., 2019. Tipifarnib modulates interferon (IFN)-γ-inducible genes in acute myeloid leukemia. Blood, 134 (Supp1): 2726. ISSN 0006-4971

FOULDS, G.A., VADAKEKOLATHU, J., ABDEL-FATAH, T.M.A., NAGARAJAN, D., REEDER, S., JOHNSON, C., HOOD, S., MOSELEY, P.M., CHAN, S.Y.T., POCKLEY, A.G., RUTELLA, S. and MCARDLE, S.E.B., 2018. Immune-phenotyping and transcriptomic profiling of peripheral blood mononuclear cells from patients with breast cancer: identification of a 3 gene signature which predicts relapse of triple negative breast cancer. Frontiers in Immunology, 9: 2028. ISSN 1664-3224

VADAKEKOLATHU, J., FOULDS, G.A., PATEL, T., REEDER, S., POCKLEY, A.G., TASIAN, S.K. and RUTELLA, S., 2018. Immune gene expression profiling identifies predictors of relapse in childhood acute myeloid leukemia. Cancer Immunology Research, 6 (9 Supp): B62. ISSN 2326-6066

RUTELLA, S., VADAKEKOLATHU, J., ALTMANN, H., PATEL, T., REEDER, S., LIANG, Y., SCHMITZ, M., HOOD, T., DANAHER, P., WARREN, S., CESANO, A., BEECHEM, J.M., POCKLEY, A.G., TASIAN, S.K. and BORNHÄUSER, M., 2018. Capturing the complexity of the immune microenvironment of acute myeloid leukemia with 3D biology technology. Journal of Clinical Oncology, 36 (5 supp), p. 50. ISSN 0732-183X

COSMA, G., MCARDLE, S.E., REEDER, S., FOULDS, G.A., HOOD, S., KHAN, M. and POCKLEY, A.G., 2017. Identifying the presence of prostate cancer in individuals with PSA levels <20 ng ml−1 using computational data extraction analysis of high dimensional peripheral blood flow cytometric phenotyping data. Frontiers in Immunology, 8, p. 1771. ISSN 1664-3224

VADAKEKOLATHU, J., PATEL, T., REEDER, S., SCHAARSCHMIDT, H., SCHMITZ, M., BORNHÄUSER, M., WARREN, S.E., HOOD, T., DANAHER, P., CESANO, A., BEECHEM, J.M., POCKLEY, A.G., TASIAN, S.K. and RUTELLA, S., 2017. Immune gene expression profiling in children and adults with acute myeloid leukemia identifies distinct phenotypic patterns. Blood, 130 (Supp 1), 3942A. ISSN 0006-4971

VADAKEKOLATHU, J., MEREDITH, R., ROSS, P.M., WAGNER, S., REEDER, S., DEMIRKAN, G., KUHAR, J.R., BALL, G.R., POCKLEY, A.G. and RUTELLA, S., 2017. Interferon-γ induces distinct mRNA and protein profiles in acute and chronic myeloid leukemia. Blood, 130 (Supp 1), 3945A. ISSN 0006-4971

HARNER-FOREMAN, N., VADAKEKOLATHU, J., LAVERSIN, S.A., MATHIEU, M.G., REEDER, S., POCKLEY, A.G., REES, R.C. and BOOCOCK, D.J., 2017. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics. Scientific Reports, 7, p. 40633. ISSN 2045-2322

DICKENSON, J.M., REEDER, S., REES, R., ALEXANDER, S. and KENDALL, D., 2003. Functional expression of adenosine A(2A) and A(3) receptors in the mouse dendritic cell line XS-106. European Journal of Pharmacology, 474 (1), pp. 43-51. ISSN 0014-2999

ALI, S.A., MCLEAN, C.S., BOURSNELL, M.E.G., MARTIN, G., HOLMES, C.L., REEDER, S., ENTWISLE, C., BLAKELEY, D.M., SHIELDS, J.G., TODRYK, S., VILE, R., ROBINS, R.A. and REES, R.C., 2000. Preclinical evaluation of 'whole' cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes. Cancer Research, 60 (6), pp. 1663-1670. ISSN 0008-5472

BOURSNELL, M.E.G., ENTWISLE, C., ALI, S.A., SIVASUBRAMANIAM, S.D., REEDER, S., MCLEAN, C.S., BLAKELEY, D.M., MILLER, J., HILL, S., SHIELDS, J.G., INGLIS, S.C. and REES, R.C., 1998. Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Gene Therapy of Cancer, 451, pp. 379-384. ISSN 0065-2598

BOURSNELL, M.E.G., ENTWISLE, C., ALI, S.A., SIVASUBRAMANIAM, S.D., REEDER, S., MCLEAN, C.S., BLAKELEY, D.M., SHIELDS, J.G., INGLIS, S.C. and REES, R.C., 1997. Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Cancer Gene Therapy, 4 (5), p. 321. ISSN 0929-1903

MCINTYRE, C.A., CHAPMAN, K., REEDER, S., DORREEN, M.S., BRUCE, L., RODGERS, S., HAYAT, K., SCHREENIVASAN, T., SHERIDAN, E., HANCOCK, B.W. and REES, R.C., 1992. Treatment of Malignant-Melanoma and Renal-Cell Carcinoma with Recombinant Human Interleukin-2 - Analysis of Cytokine Levels in Sera and Culture Supernatants. European Journal of Cancer, 28 (1), pp. 58-63. ISSN 0959-8049